To: NATIONAL EDITORS
Contact: John Murphy of Mayo Clinic, +1-507-284-5005 (days), +1-
507-284-2511 (evenings), newsbureau@mayo.edu
ROCHESTER, Minn., Dec. 12 /PRNewswire-USNewswire/ — When a
vaccine to prevent shingles was approved for use in 2006, the Food
and Drug Administration recommended the vaccine for people age 60
and older who previously had chickenpox. But two issues — the
vaccines cost and the perception that shingles primarily affects
adults with weakened immune systems — have left some physicians
undecided about whether healthy adults need the vaccine. This
uncertainty prompted a …
Read the rest of this article with a Free Trial at HighBeam Research.
Information provided by: Findarticles.com
